market Reports

Research Report on China's Escitalopram Market, 2021-2025

SKU ID : CRI-19159369

No. of pages : 40

Publishing Date : 16-Sep-2021

Detailed TOC of Research Report on China's Escitalopram Market, 2021-2025

Table of Contents
1 Relevant Concept of Roxatidine
1.1 Indications of Roxatidine
1.2 Development of China’s Roxatidine Market
1.3 Governmental Approval of Roxatidine in China
1.4 The Impact of COVID-19 on China’s Roxatidine Market

2 Sales of Roxatidine in China, 2016-2020
2.1 Sales Value
2.1.1 Sales Value in China
2.1.2 Sales Value in China by Region
2.2 Sales Volume
2.2.1 Sales Volume in China
2.2.2 Sales Volume in China by Region
2.3 Sales of Roxatidine in China by Dosage Form, 2016-2020
2.3.1 Injection
2.3.2 Other Dosage Forms

3 Analysis of Major Roxatidine Manufacturers in China, 2020
3.1 Analysis of Market Share
3.1.1 Market Share of Manufacturers by Sales Value
3.1.2 Market Share of Manufacturers by Sales Volume
3.2 Beijing Sihuan Pharmaceutical Co., Ltd.
3.2.1 Company Profile
3.2.2 Sales of Roxatidine in China
3.3 HPGC Bioengineering
3.3.1 Company Profile
3.3.2 Sales of Roxatidine in China

4 Sales Price of Roxatidine of Different Companies in China, 2020-2021
4.1 Beijing Sihuan Pharmaceutical Co., Ltd. (Jieao®)
4.2 HPGC Bioengineering (Ruishi®)

5 Prospects of China’s Roxatidine Market, 2021-2025
5.1 Influencing Factors for the Market Development
5.1.1 The Impact of COVID-19 on the Market
5.1.2 Market Drivers and Opportunities
5.1.3 Market Threats and Challenges
5.2 Forecast on Market Size
5.3 Forecast on Market Trend

List of Charts
Chart Patent Information of Roxatidine in China
Chart Sales Value of Roxatidine in China, 2016-2020
Chart Sales Volume of Roxatidine in China, 2016-2020
Chart Sales Volume of Roxatidine in China by Region, 2016-2020
Chart Sales Value of Roxatidine in China by Region, 2016-2020
Chart Market Share of Roxatidine Manufacturers in China by Sales Value, 2016-2020
Chart Sales Value and Volume of Roxatidine (of Beijing Sihuan Pharmaceutical Co., Ltd.) in China, 2016-2020
Chart Sales Value and Volume of Roxatidine (of HPGC Bioengineering) in China, 2016-2020
Chart Sales Price of Roxatidine (of Beijing Sihuan Pharmaceutical Co., Ltd.) in China, 2016-2020
Chart Sales Price of Roxatidine (of HPGC Bioengineering) in China, 2016-2020
Chart Forecast on Sales Value of Roxatidine in China, 2021-2025
Chart Forecast on Sales Volume of Roxatidine in China, 2021-2025

Keyplayers in Research Report on China's Escitalopram Market, 2021-2025

1 Beijing Sihuan Pharmaceutical Co., Ltd. (Jieao®)
2 HPGC Bioengineering (Ruishi®)
market Reports market Reports